William Little
Sophomore Member
- Joined
- Feb 23, 2006
- Professional Status
- Certified Residential Appraiser
- State
- Colorado
Maybe the market is declining hence comparable sales prices are mostly higher than the subject contract price.
That is exactly right...That is a pretty good point. Assuming that the 750k report sample is all Corelogic appraisals, it is only representative of their panel.
View attachment 32254
I thought this was interesting. The data seems to suggest that comparables are being selected by price.
Well that's one opinion/conclusion.
Another might be that across the board, appraisers are submitting reports that adequately support their opinion of value, using the client preferred and recognized technique of presenting market evidence known as bracketing. The insinuation appearing to be made, and correct me if I am wrong, is that appraisers are hitting the sales contract price in some diabolical way. Prices are up almost everywhere and the majority of sales contracts fall within the probable range, so...I don't see what the big surprise is and why the cry of wolf. The data appears exactly as I would expect it to. If reports had 4 comps instead of 3, the percentage would likely be 50/50. A client would prefer to see 2 of the 3 be higher than the opinion, not the other way around, so...
You guys really need to take a look at the lower left of the chart posted in post 1 of this thread which discloses that the data utilized are from FNC's National Collateral Database which means that these are not all CoreLogic appraisalsThat is exactly right...
I don't know what that has to do with comparable selection. You are suggesting that the comps are being selected for reasons other than property characteristics.
I am just saying that the distribution chart is interesting. Raises some questions for sure.
I am not just suggesting comps are selected for reasons other than property characteristics, I am saying it directly. USPAP does not say provide sales data with similar property characteristics, it says provide relevant market evidence. Seems to me the price would be relevant to provide support for the opinion, no?